SIR Position Statement Supports Genicular Artery Embolization to Treat Symptomatic Knee Osteoarthritis

May 13, 2026—The Society of Interventional Radiology (SIR) announced the publication of a position statement that provides evidence-based support for the use of genicular artery embolization (GAE) as a minimally invasive treatment option for patients with symptomatic knee osteoarthritis (KOA) who have failed conservative therapy and are not candidates for, or wish to delay, total knee arthroplasty.

FDA Clears Six New Interventional Systems for Siemens’s Optiq AI Imaging Chain

May 13, 2026—Siemens Healthineers announced it has received FDA clearance for six new systems in its Artis interventional imaging portfolio, all of which feature the company’s new artificial intelligence (AI)–powered imaging chain, Optiq AI, to analyze and optimize image data in real time.

HistoSonics Edison Histotripsy System Submitted for FDA Approval of Kidney Tumor Indication

May 13, 2026—HistoSonics announced it has submitted a de novo request to the FDA seeking authorization to expand the use of its Edison histotripsy system to include the destruction of kidney tumors.

Artivion Exercises Option to Acquire Endospan

May 8, 2026—Artivion, Inc., headquartered in suburban Atlanta, Georgia, will acquire Israel-based Endospan, a developer of solutions for the endovascular repair of aortic arch disease.

Stryker Completes Acquisition of Amplitude Vascular Systems

May 8, 2026—Stryker announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), which is developing a next-generation intravascular lithotripsy platform designed to treat complex peripheral arterial disease.

DISTALS Trial Data Presented for Rapid Medical Tigertriever 13 in DMVO Stroke

May 7, 2026—Rapid Medical announced full results from the DISTALS randomized clinical trial demonstrating that the company’s Tigertriever 13 thrombectomy system can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke.

Cordis Selution SLR PTA Drug-Eluting Balloon Launched in Japan 

May 6, 2026—Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon (DEB) for the treatment of peripheral artery disease.

QoL Analysis Reported From PROMISE III Trial of Transcatheter Arterialization of the Deep Veins for CLTI

May 6, 2026—Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment options experienced significant quality of life (QoL) improvements after undergoing transcatheter arterialization of the deep veins (TADV).